Tag: Antibiotics

Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza, and their inappropriate use allows the emergence of resistant organisms. Drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics.
Sometimes the term antibiotic (which means “opposing life”) is used to refer to any substance used against microbes, synonymous with antimicrobial. Some sources distinguish between antibacterial and antibiotic; antibacterials are used in soaps and disinfectants, while antibiotics are used as medicine. Antibiotics revolutionized medicine in the 20th century, and have together with vaccination led to the near eradication of diseases such as tuberculosis in the developed world. However, their effectiveness and easy access led to overuse, especially in livestock raising, prompting bacteria to develop resistance. This has led to widespread problems with antimicrobial and antibiotic resistance, so much as to prompt the World Health Organization to classify antimicrobial resistance as a “serious threat [that] is no longer a prediction for the future, it is happening right now in every region of the world and has the potential to affect anyone, of any age, in any country”. All classes of antibiotics in use today were first discovered prior to the mid 1980s.

Civica and Xellia Agreed to Cooperate to Reduce Drug Shortages

Civica Rx (Civica, Inc.) and Xellia Pharmaceuticals announced they have signed a product supply agreement under which Xellia will manufacture essential antibiotics, including Vancomycin and Daptomycin...

Biokhimik Received Certificate for First Russian Generic Doripenem

JSC "Biokhimik", the leader in the production of antibiotics in the Russian Federation received a registration certificate for the production of the generic Doripenem – the first in the country. This ...

Forge and Basilea Announced a Research Collaboration To Discover And Develop Novel Antibiotics

Forge Therapeutics, Inc. (Forge) and Basilea Pharmaceutica International Ltd. (Basilea), a wholly-owned subsidiary of Basilea Pharmaceutica Ltd., announced today that they have entered into a research...

FEDEGARI: Cost-effective Solution for Sterile Antibiotic Powder Filling of Al-kegs

According to the FDA (Food and Drugs Administration), pharmaceutical manufacturing has been well known for its inefficient and costly operations (2004). Recently, the need to increase efficiency and r...

UK Breakthrough Plan for AMR

A new reimbursement model for antibiotics by the NHS and NICE is being labelled as a ‘great breakthrough’. The model is part of the government’s new national action plan on how it will fight agains...

GARDP, Eisai and Takeda join Forces to search new Antibiotics

Under a new agreement the Japanese pharma companies will access and screen molecules from Eisai and Takeda’s chemical libraries. Both libraries will be tested by the Institut Pasteur Korea, in order t...

PhagoMed Biopharma receives ‘Phönix 2018’ award in Austria

Vienna-based Biotech company PhagoMed Biopharma was awarded the Austrian Entrepreneurship Award 'Phönix 2018' in the category “Start-Up International”.

EMA recommends to restrict the use of fluoroquinolone and quinolone antibiotics

european medicines agency
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restricting the use of fluoroquinolone and quinolone antibiotics.

Sales of veterinary antimicrobials in Europe decreased by about 20%

A new report published by European Medicines Agency (EMA) shows that the overall sales of veterinary antimicrobials across Europe have decreased by more than 20% between 2011 and 2016.

Paratek Pharmaceuticals seeks EMA approval for its novel antibiotic

Paratek Pharmaceuticals (USA) announced the acceptance of the submission to the European Medicines Agency (EMA) of the Marketing Authorization Application (MAA) for omadacycline.

Boston Pharmaceuticals licenses three anti-infective programs from Novartis

antimicrobial resistance
Novartis has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates.

Dr Reddy’s sells its US manufacturing facility to UAE pharma company

dr reddy s
Dr Reddy’s Laboratories has sold the antibiotics manufacturing facility and related assets it had acquired in Bristol, Tennessee (USA), from GlaxoSmithKline (GSK) seven years ago.

GARDP and Novartis to cooperate on enhancing generic antibiotics

microbiology plates
The Global Antibiotic Research & Development Partnership (GARDP) and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children.

Genentech antibiotic displays high activity against superbugs

antibiotic resistance
Recently published findings demonstrate that optimized arylomycin analogues could translate into new therapies to address the growing threat of multidrug-resistant Gram-negative infections.

Bioengineers discovered promising antibiotic candidates

Researchers from The Massachusetts Institute of Technology and the University of Naples Federico II found that fragments of the protein pepsinogen can kill bacteria such as Salmonella and E. coli.

CFU scientists develop phytobiotics from Crimean wild plants

Phytobiotics, a biologically active substance isolated from plants, can become a real alternative to antibiotics, improve the immunity of patients and fight hospital infections